All Danish first-time COPD hospitalisations 2002–2008: Incidence, outcome, patients, and care  by Lykkegaard, Jesper et al.
Respiratory Medicine (2012) 106, 549e556Available online at www.sciencedirect.com
journal homepage: www.elsevier .com/locate/rmedAll Danish first-time COPD hospitalisations
2002e2008: Incidence, outcome, patients, and careJesper Lykkegaard a,*, Jens Søndergaard a, Jakob Kragstrup a,
Jesper Rømhild Davidsen a,b, Thomas Knudsen a, Morten Andersen a,caResearch Unit of General Practice, Institute of Public Health, University of Southern Denmark, J. B. Winsløws Vej 9A, 1,
DK-5000 Odense C, Denmark
bDepartment of Respiratory Medicine, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark
cCenter for Pharmacoepidemiology, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Received 25 August 2011; accepted 2 November 2011
Available online 23 November 2011KEYWORDS
COPD;
Hospitalization;
Incidence;
Mortality;
Threshold;
Trend* Corresponding author. Tel.: þ45 65
E-mail address: jlykkegaard@healt
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2011.11.001Summary
Objective: This study aimed to investigate trends in first-time hospitalisations with chronic
obstructive pulmonary disease (COPD) in a publicly financed healthcare system during the
period from 2002 to 2008 with respect to incidence, outcome and characteristics of hospitali-
sations, departments, and patients.
Methods: Using health administrative data from national registers, all first-time hospitalisa-
tions with COPD in Denmark (population 5.4 million) were identified. Data based on the indi-
vidual hospitalisations and patients were retrieved and analysed.
Results: During the period 2002 to 2008 the total rate of COPD hospitalisations decreased from
460 to 410 per 100 000 person years. Among persons above 45 years of age, the age- and sex-
adjusted incidence rate of first-time COPD hospitalisations decreased by 8.2% (95% CI 5.0-
11.2%). The inpatient mortality increased OR 1.16 (95% CI1.01-1.34) and the one-year mortality
increased OR 1.12 (95% CI1.03-1.21). Concurrently, significant age- and sex-adjusted increases
were found in use of intensive care, comorbidity, patient travel distance, bed occupancy rate
of the receiving department, prior use of oral and inhaled corticosteroids, use of outpatient
clinics and encounters in general practice, while length of stay and number of receiving hospi-
tals decreased.
Conclusion: Decreasing rate of first-time COPD hospitalisations combined with shorter lengths
of stay and increasing severity of cases indicates that the use of hospital beds for COPD exac-
erbations has been gradually restricted. This may be causally related to both the centralisation
into overcrowded departments and the improved outside hospital treatment of COPD, also
demonstrated in this study.
ª 2011 Elsevier Ltd. All rights reserved.50 3967; fax: þ45 6550 3980.
h.sdu.dk (J. Lykkegaard).
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been used since 1994. Data are registered with theCOPD exacerbation is among the most frequent causes of
hospitalisation.1 In year 2000, the diagnosis accounted for
the third most hospital bed days in England.2 In Denmark,
the annual number of patients hospitalised with COPD more
than doubled from 1991 to 2001.3 However, recent studies
from developed countries report decreasing COPD preva-
lences,4e7 and the rate of COPD hospitalisations in both the
US8 and Denmark9 has been slightly decreasing since the
late nineties.
In Denmark and most other developed countries tobacco
consumption has been decreasing since the seventies,10 and
this may be the main reason why the rates of COPD hospi-
talisations have decreased. However, changes in the
healthcare systems affecting the severity threshold for
hospital admission and discharge of COPD patients may also
play an important role which has not been investigated in
previous studies.
In the last decade, the European healthcare infrastruc-
ture has been increasingly specialised into fewer units with
larger patient volumes. These changes aim to provide cost
savings from economies of scale and to improve quality of
care. Evidently, mortality as well as length of stay can be
lowered by providing COPD hospitalised patients with more
specialist respiratory staff and improved high quality
evidence-based care such as non-invasive positive pressure
ventilation.1,11,12 However, closing smaller hospitals and
building fewer but larger ones mean that many patients
must travel further to be hospitalised, while at the same
time the number of acute care beds has been reduced
throughout the developed world.13 In Denmark, the total
number of beds in medical departments decreased from
6970 in January 2002 to 6087 in December 2008.14 Such
changes may have increased the severity threshold of COPD
hospitalisation in Denmark as well as in other countries with
a similar trend within secondary healthcare.
This study aimed to investigate trends in first-time hos-
pitalisations with COPD in a publicly financed healthcare
system during the period from 2002 to 2008 with respect to
incidence, outcome and characteristics of hospitalisations,
departments, and patients.
Methods
Design
We conducted a register-based time trend analysis covering
the whole Danish population (5.43 million in 200815).
Setting
All COPD hospitalisations in Denmark are in public hospitals
and occur either by referral from a general practitioner
(GP) or in severe cases as a direct emergency admission.
The Danish healthcare system is free of charge and with
equal access for all citizens. Administrative data from all
hospitalisations in Danish hospitals, including diagnoses
classified according to International Classification of
Diseases (ICD), have been recorded by the Danish NationalPatient Registry since 1977.16 ICD 10th revision (ICD-10) has
patient’s unique civil registration number allowing indi-
vidual level linkage to all national registers.17
Definition of first-time COPD hospitalisation
COPD hospitalisation was defined as any hospitalisation
with either ICD-10 codes J41-44 (chronic bronchitis,
emphysema, or COPD) as primary diagnosis or with J13-18
(pneumonia) or J96 (respiratory failure) as primary diag-
nosis combined with either J41-44 as one of the secondary
diagnoses.16
Between January 1994 and December 2008 all subjects
aged 45 years and above on the date of admission to
hospital with COPD were identified. In order to determine
whether it was a first-time COPD hospitalisation, we used
individual 8-year look-back periods. A person was classified
as prevalent from the first COPD hospitalisation until either
death, migration, or the end of an 8-year period with no
COPD hospitalisations. We linked the individual health
administrative data with data from the Demographic
Register in order to obtain dates of birth, death and
migrations to or from Denmark. This register also provided
numbers of the total Danish population by age and sex for
the years 2002e2008. Age- and sex-specific monthly inci-
dence rates of first-time COPD hospitalisations were
calculated by dividing the number of first-time cases with
the population at risk (the annual Danish population minus
the prevalent cases at the beginning of the month in
question). The age limit of 45 years was chosen because
COPD is rare in younger people and we wanted to reduce
the inclusion of misclassified asthmatics.8 The 8-year look-
back period and 7-year study period were chosen because
ICD-10 classified data were only available from year
1994e2008 and we wanted to avoid the possibility of the
same subject being regarded as first-time hospitalised
twice in our study period.
Characteristics of hospitalisations and patients
From the Danish National Board of Health we annually
retrieved names, addresses, medical specialities, and bed
occupancy rates for all Danish hospital departments during
the study period. We linked these data with the patient-
specific data by use of admission year and department
identification codes. Using the patients’ civil registration
numbers and dates of first-time COPD hospitalisations we
retrieved the following register data on the patients: The
Demographic Register provided home addresses of the
patients in the year of hospitalisation, so that travel
distance between the patients’ homes and the receiving
hospitals could be calculated. The Register of Medical
Products Statistics comprises information on every medical
product sold on prescription in Danish pharmacies since
1994. It provided dates and anatomical-therapeutic-chem-
ical (ATC) codes on each drug sold to every patient. The
Primary Health Care Database comprises individually linked
information on every service provided by Danish GPs since
1990. It provided dates and service codes for each patient
of all encounters in general practice.
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Analysis
For every annual cohort of first-time hospitalised COPD
patients we calculated the proportion of inpatient deaths,
and of deaths within one year from admission. We also
calculated the average length of stay, the proportion of
hospitalisations with stay on a ward classified as an inten-
sive care unit, the proportion of hospitalisations more than
25 km from the patient’s home address, the average
Charlson comorbidity index (excluding COPD), and the
average number of prior all-cause hospitalisations. The
latter two were based on every patient’s individual 8-year
periods prior to their first COPD hospitalisation. The
Charlson index was calculated by means of ICD-10 coded
diagnoses from all in- and outpatient admissions.18
For one year prior to the patients’ first COPD hospital-
isation we calculated the patients’ average number of
encounters in general practice, and the proportion of
patients having had spirometry in primary care, outpatient
hospital treatment for COPD, and prescriptions of inhaled
COPD medication and oral steroids. Finally we calculated
averageannual bedoccupancy rates basedon the report from
each patient’s receiving department in the year of reception.
Statistics
The 2002 and 2008 incidence rates of first-time COPD hos-
pitalisations were compared using direct age- and sex-
standardisation to the Danish 2008 population. Trends in
first-time incidence rates were estimated by means of
Poisson regression with calendar year as the primary inde-
pendent variable. Trends in outcome and characteristics
were estimated by means of either logistic regression
models or linear regression models. Bootstrap estimations
were used in the linear models due to variance heteroge-
neity of the residuals. In all models we adjusted for age and
sex, and both the annual change and the total change from
2002 to 2008 were investigated. Coefficient plots and like-
lihood tests of fractional polynomials confirmed that it was
reasonable to use year as a continuous variable without
transformation. All analyses were performed using STATA
Release 10.1 (STATACorp, College Station, TX, USA).
Results
During the period from 2002 to 2008 a total of 47 728
subjects were hospitalised 161 993 times with COPD in
Denmark. Some 99.9% of the hospitalisations took place in
public hospitals and 96% were admissions to departments of
internal medicine.
The annual rate of COPD hospitalisations decreased from
460 to 410 per 100 000 person years, while the number of
hospitals receiving COPD patients decreased from 70 to 58.
Among the Danish population aged 45 years and above,
the age- and sex-standardised incidence rate of first-time
COPD hospitalisations decreased from 330 to 300
per 100 000 person years. The age- and sex-adjusted inci-
dence rate ratio between 2008 and 2002 was 0.92 (95% CI0.89e0.95), and analysing data for all the years, the
adjusted decrease in the incidence of first-time hospital-
isations was 1.2% per year (95% CI 0.8e1.7%) (Table 1).
There was a large seasonal variation in both the total
number of hospitalisations and the rate of first-time hos-
pitalisations (Fig. 1).
The decrease in the incidence of first-time COPD hos-
pitalisations was predominantly among males aged 60e79
years. In contrast, there were significant increases in the
incidence among females aged 80 years and older (Table 1).
In total, throughout the period around 46% were males, and
the average age increased from 71.6 to 72.2 years (Table 2).
During the study period, the age- and sex-adjusted all-
cause inpatient and one-year mortalities increased. Both
inpatient and one-year age-adjusted mortality was higher
in males than in females. The increase in inpatient
mortality was predominantly among males, while the
increase in one-year mortality was equal among the sexes.
Further age- and sex-adjusted trends in the character-
istics of patients and hospitalisations were as follows: The
use of intensive care units increased. So did the comor-
bidity of the patients both in terms of the Charlson index
and the number of all-cause prior hospital admissions. The
patients’ prior diagnoses with cardiovascular disease, dia-
betes, cancer, and other diseases all increased substan-
tially and gradually throughout the period.
The proportion of patients who travelled beyond 25 km
to hospital more than doubled, while the average bed
occupation rate of the receiving departments increased
beyond fully occupied. Meanwhile the average length of
stay decreased.
Regarding the year prior to the first COPD hospital-
isation: The proportion of patients treated in outpatient
hospital clinics for COPD increased. The proportion of
patients who had a spirometry in primary care and the
frequency of primary care encounters also increased
except for home visits, which became fewer in the daytime
while visits after hours remained constant. The proportions
increased of patients who in the year prior to admission had
redeemed at least one prescription for, respectively,
inhaled long-acting beta-2 agonists, tiotropium, and corti-
costeroids (oral as well as inhaled). The proportion of
patients who had redeemed a prescription for inhaled
short-acting bronchodilators (beta2agonists or anticholin-
ergics) decreased.
All the above trends were extremely significant, espe-
cially when analysing data for all the years instead of just
comparing year 2002e2008 (Tables 1 and 2).
The number of first-time hospitalisations with ICD-10
codes J41-43 (chronic bronchitis or emphysema) as opposed
to J44 (COPD) decreased more than the total decrease in
first-time COPD hospitalisations (Table 2). Based on the
2002 hospitalisations, mean age, gender, mortality,
comorbidity, use of intensive care, and encounters in
general practice did not differ between these two groups,
but compared to those coded with J44, patients coded with
J41-43 were less often treated with inhalation drugs and
less often treated for COPD in outpatient clinics. They were
admitted to less crowded departments, which were less
often specialised in internal medicine and to which they
had to travel a bit further (Table 3). Patients coded with
J13-18 (pneumonia) or J96 (respiratory failure) had a much
Table 1 First-time COPD hospitalisations in Denmark 2002 e 2008.
2002 2008 Change 2002 e 2008
No. with
new COPD
Population
at risk
IR per
1000
years
No. with
new COPD
Population
at risk
IR per
1000
years
IRR2008/2002age-
& sex-adj.
IRR Annualage-
& sexeadj.
Females aged
45e59 years 547 554,604 1.0 500 542,811 0.9 0.94(0.83e1.06) 0.99(0.97e1.00)
60e79 years 2314 443,831 5.2 2133 510,584 4.2 0.80(0.75e0.85) 0.97(0.96e0.97)
80 þ years 829 140,690 5.9 1059 142,396 7.5 1.27(1.16e1.39) 1.04(1.03e1.05)
All ages 3690 1,139,125 3.2Std 3692 1,195,791 3.1 0.96(0.92e1.01) 0.99(0.99e1.00)
Males aged
45e59 years 441 564,963 0. 8 455 549,879 0.8 1.06(0.93e1.21) 1.01(0.99e1.03)
60e79 years 2051 388,047 5.3 1779 472,420 3.8 0.71(0.67e0.76) 0.95(0.94e0.95)
80 þ years 767 68,945 11.2 867 74,866 11.6 1.05(0.95e1.15) 1.02(1.00e1.03)
All ages 3259 1,021,955 3.3Std 3101 1,097,165 2.8 0.87(0.83e0.91) 0.98(0.97e0.99)
Overall aged
45e59 years 988 1,119,567 0.9 955 1,092,690 0.9 0.99(0.91e1.09) 1.00(0.99e1.01)
60e79 years 4365 831,878 5.3 3912 983,004 4.0 0.76(0.73e0.79) 0.96(0.95e0.96)
80 þ years 1596 209,635 7.6 1926 217,262 8.9 1.16(1.09e1.24) 1.03(1.02e1.04)
All ages 6949 2,161,080 3.3 Std 6793 2,292,956 3.0 0.92(0.89e0.95) 0.99(0.98e0.99)
Analysed using Poisson regression. Age- & sex-adjusted when appropriate. 95% confidence intervals in parentheses.
Abbreviations: IR, Incidence Rate; IRR2008/2002, IR ratio comparing 2008 with 2002; IRRannual, IR ratio for the increase of one calendar year
calculated using all annual data during 2002e2008; Std Standardised on the Danish 2008 population.
552 J. Lykkegaard et al.higher mortality, comorbidity, and use of intensive care
units than patients coded with J44 or J41-43.Discussion
This study showed that during the period 2002 to 2008 the
total number of COPD hospitalisations in Denmark
decreased along with the adjusted rate of first-time COPD
hospitalisations. Decreases were mainly among males aged
60e79 years while the rate among women older than 79
years increased. This gender difference probably reflects
increases in female smoking relative to men in Denmark in
the second half of the 20th century.13 Likewise, after 30
years of decreases in the total Danish tobacco consump-
tion,10 the decreases in COPD hospitalisations might be
interpreted as representing decreases in the incidence of
the disease. However, changes in the other parameters
included in this study led to a different conclusion.
Substantial increases were consistently found in several
indicators of case severity, including mortality, comorbid-
ity, use of intensive care unit, and prior use of oral corti-
costeroids. The combination of decreasing rates of
hospitalisations and increasing severity of hospitalised
patients indicates that the severity threshold of hospital
admission increased,19 so that less severe cases were more
seldom admitted to hospital. It is not known whether this
was because the GPs independently became better at
treating exacerbations outside hospital and in selecting the
correct patients for hospitalisation, or the development
was forced by reductions in the number of hospital beds.
Length of stay is usually an indicator of severity.
However, in the study period the number of hospitals and
beds was reduced, the patients had to travel further, andthe departments were increasingly overcrowded and all
other factors point in the direction of increasing severity.
Therefore, we believe that the decreases in length of stay
resulted from a combination of increased restrictions in the
use of COPD hospital beds, shortening length of stay by
lowering the threshold for discharge, and a possibly
improved efficacy inside hospitals, which may have resul-
ted in shorter lengths of stay regardless of the disease
severity among the hospitalised COPD patients. Impor-
tantly, the decreasing total number of COPD hospital-
isations shows that the increased conduct of early discharge
did not result in more readmissions.
While GPs treated increasingly severe COPD exacerba-
tions outside hospital, the proportion of COPD patients
medicated according to guidelines prior to their first hos-
pitalisation improved substantially, perhaps explaining
a reduction in the use of inhaled short-acting bronchodi-
lators. There was also an improvement in the proportions of
COPD hospitalised patients who had had a spirometry in
general practice and who had treatment for COPD in
outpatient clinics.
Our findings are interesting to other countries since
international trends and characteristics of COPD hospital-
isations seem to be similar. In both Denmark and the US, the
rate of COPD hospitalisations increased rapidly during the
nineties and then rather suddenly started to
decline.3,8,9,20,21 Similar to our findings, repeated UK audits
in 2003 and 2008 have shown an increase in the average
case severity of COPD hospitalised patients.22 The inpatient
mortality, age, gender, and length of stay found in these
audits were almost identical to our findings.1 A 2005 audit
from Norway and Sweden showed the same length of stay as
in our study, but slightly older age of the patients and an
inpatient mortality of only 3.7%23. Furthermore, both the
Figure 1 Total COPD hospitalisations, standardised incidence rate of first-time hospitalisations, and standardised inpatient
mortality (running 3 month average). All standardisations are direct on the age distribution of the 2008 Danish population.
Incidence, outcome, patients, and care 553levels of mortality and the excess mortality in males found
in our study are in accordance with a recently published
large observational study from Canada.24 In contrast to our
findings, the inpatient mortality of COPD patients in Danish
specialised pulmonary departments has probably improved
during our study period.25 However, a minority of Danish
COPD hospitalisations is to specialised pulmonary depart-
ments and our study included all COPD hospitalisations and
departments including those of no or other speciality, in
which the development has evidently been different. The
high completeness of our data is probably also a reason why
the total rate of COPD hospitalisations in our study is higher
than in studies from the US,8,20,21 Norway, Sweden,23 and
France.26 However, for decades the proportion of daily
smokers has been much higher in Denmark relative to other
developed countries, especially among women.13Strengths and limitations
The ability of this study to exclusively identify all first-time
cases and compare monthly changes in incidence rates with
simultaneous changes in several characteristics is unique.
The study covers every individual in a whole nation for 15
years using the same disease classification, ICD-10. Data onall hospitalisations, deaths and migrations were available
and prospectively collected, avoiding recall bias and
providing exact onsets for calculation of incidence. Access
to COPD hospitalisation was equal and free of charge for all
Danish citizens throughout the period and decisions to
hospitalise were made by specialists in general medicine.
There was no intermediate option between hospitalisation
and primary care treatment which could bias the result.
Misclassification of the COPD diagnosis is a potential
limitation of our study, since no spirometry data were
available to secure the diagnosis and severity of cases.
Some COPD diagnoses may be wrong and some COPD
patients may have been misdiagnosed, for instance with
pneumonia or cardiac failure.16,27 However, the diagnoses
obtained from the Danish National Registry of Patients were
coded by the doctor in charge of the discharge and vali-
dated in a 2008 nationwide study which found a positive
predictive value of 0.92 for COPD.16 As suggested in the
validation paper we added the codes J41-43 (chronic
bronchitis and emphysema) to the COPD definition in order
to minimize the influence of diagnostic drift. As shown in
Table 3, there were big differences between patients
included by different sets of diagnoses, but hospitalisations
coded with J41-43 did not particularly differ compared to
J44. The decrease in Danish COPD hospitalisations probably
Table 2 Trends in first-time COPD hospitalisations in Denmark during 2002e2008.
2002 2008 Age- and sex-adjusted logistic regression
No. first-time COPD hospitalisations 6949 6793 OR2008/2002(CI95%) OR annual(CI95%) Ptrend
No. receiving hospitals 70 58
% of cases % of cases
Diagnosis code
J44 prim. 67.8 62.2 0.79(0.74e0.85) 0.97(0.96e0.98) <0.001
J13-18 prim. þ J44 sec. 15.5 21.2 1.45(1.33e1.58) 1.05(1.04e1.06) <0.001
J96 prim. þ J44 sec. 5.9 9.9 1.76(1.55e2.00) 1.10(1.09e1.12) <0.001
J41e43 prim. 7.7 4.9 0.61(0.53e0.70) 0.91(0.89e0.93) <0.001
J13-18 prim. þ J41e43 sec. 2.6 1.3 0.49(0.38e0.63) 0.89(0.86e0.91) <0.001
J96 prim. þ J41e43 sec. 0.5 0.5 0.98(0.60e1.61) 1.02(0.96e1.08) 0.53
Male gender 46.9 45.6 0.95(0.89e1.02) 0.99(0.98e1.00) 0.17
One-year mortality 23.2 25.9 1.12(1.03e1.21) 1.02(1.01e1.03) 0.001
Inpatient mortality 5.9 7.0 1.16(1.01e1.34) 1.03(1.01e1.05) 0.002
Stay in intensive care unit 1.2 1.7 1.42 (1.07e1.88) 1.09(1.05e1.13) <0.001
Department of internal medicine 96.0 96.0 0.97(0.82e1.15) 0.99(0.96e1.00) 0.23
Private hospital 0.01 0.09 e e e
Travel distance > 25 km 10.5 21.9 2.43(2.21e2.68) 1.16(1.15e1.18) <0.001
COPD outpatient 1 year prior 9.4 11.1 1.25(1.12e1.40) 01.04(1.03e1.06) <0.001
GP spirometry 1 year prior 14.6 17.6 1.31(1.20e1.44) 1.05(1.04e1.07) <0.001
Prescriptions 1 year prior
Short-acting bronchodilators 81.3 58.2 0.60(0.56e0.64) 0.92(0.91e0.93) <0.001
Long-acting beta2agonists 33.6 45.8 1.74(1.62e1.87) 1.10(1.09e1.11) <0.001
Inhaled corticosteroids 49.2 54.5 1.26(1.17e1.34) 1.04(1.03e1.05) <0.001
Tiotropium 4.0 27.2 9.57(8.39e10.93) 1.21(1.20e1.23) <0.001
Oral corticosteroids 8.7 9.8 1.11(0.99e1.25) 1.04(1.02e1.05) <0.001
Mean Mean Age- and sex-adjusted linear regression
2008e2002(CI95%) Annual(CI95%) Ptrend
Age/years 71.6 72.2 0.66(0.26e1.05) 0.13(0.08e0.18) <0.001
Length of stay/days 8.8 8.4 0.43(0.830.03) 0.08(0.130.03) 0.003
No. prior all-cause hospitalisations 3.1 3.7 0.53(0.38e0.68) 0.09(0.07e0.11) <0.001
Comorbidity (Charlson) 1.03 1.28 0.25(0.20e0.30) 0.04(0.03e0.05) <0.001
Bed occupancy rate/% 99 102 2.5(2.0e3.1) 0.27(0.20e0.34) <0.001
GP encounters 1 year prior
Consultations 7.4 9.1 1.82(1.53e2.11) 0.31(0.27e0.35) <0.001
Telephone consultations 11.9 13.1 0.99(0.48e1.51) 0.16(0.10e0.22) <0.001
Home visits daytime 1.26 1.06 0.30(0.390.19) 0.05(0.060.03) <0.001
Home visits out-of-hours 0.72 0.72 0.03(0.06e0.00) 0.00(0.01e0.00) 0.22
Abbreviations: OR, Odds Ratio; CI, confidence interval; Ptrend, p-value of an annual trend throughout the period; prim., primary diag-
nosis; sec., secondary diagnosis.
554 J. Lykkegaard et al.transpired in J41-43 coded hospitalisations because during
the study period Danish pulmonologists and the Danish
National Board of Health increasingly recommended the use
of J44 instead of J41-43.16,28 Furthermore, in our study
period the funding of Danish hospitals was increasingly
based on the type and number of diagnoses, creating an
incentive for more precise coding. A diagnostic drift
generated due to increased coding incentives would bias
our findings towards underestimating the true decrease in
COPD hospitalisations. In contrast, the increased coding
incentives could explain some of the increase that we found
in the average comorbidity index of COPD patients.
However, COPD patients from recent years also have
a higher number of previous all-cause hospitalisations,and we therefore believe that they actually have more
comorbidity. Furthermore, the increase in mortality found
in our study may be underestimated, because patients
hospitalised late in the period most likely received an
improved treatment, for instance by increased use of non-
invasive positive pressure ventilation. The increase in this
specific treatment may on the other hand partly explain the
huge increase in the use of intensive care, because in most
Danish hospitals this treatment required admission to an
intensive care unit.
The combination of decreasing rate of first-time COPD
hospitalisations and increasing severity might be explained
by restriction in the use of the COPD diagnoses instead of
restriction in hospitalisations of COPD patients. This is,
Table 3 First-time COPD hospitalisations in Denmark 2002 characterised according to diagnosis codes.
COPD defining diagnosis: Chronic obstructive pulmonary disease
(J44)
Chronic bronchitis or emphysema
(J41-43)
Primary diagnosis: J44 Pneumonia
(J13-18)
Resp. failure
(J96)
J41-43 Pneumonia
(J13-18)
Resp. failure
(J96)
[Age] years 71.2 73.2 71.3 71.2 74.3 71.1
Male gender % 46.1 51.1 40.9 47.2 52.7 65.6
Inpatient mortality % 4.1 8.6 16.3 5.1 7.1 40.6
One-year mortality % 21.4 27.6 32.1 21.1 22.5 56.3
Intensive care unit % 0.5 1.2 10.0 0.4 5.5 12.5
Department of internal medicine % 97.7 95.2 91.5 95.9 94.5 96.9
[Department Occupancy rate] 99 101 105 98 98 99
Travel distance > 25 km % 10.7 10.0 8.8 11.7 12.1 6.3
[Charlson comorbidity index] 0.99 1.16 1.28 0.92 1.12 1.16
COPD outpatient 1 year % 9.7 7.2 15.1 8.5 5.5 6.3
Inhaled corticosteroids 1 year % 50.1 49.2 49.4 40.4 42.9 28.1
Long-acting beta2agonists1 year % 35.4 31.3 32.3 25.8 27.5 31.3
Shorteacting bronchodilators 1 year % 85.6 70.3 80.3 71.8 66.5 75.0
[No. GP consultations 1 year] 7.6 6.9 6.4 7.3 7.9 8.5
[No. GP telephone consultations 1 year] 12.0 12.0 11.0 12.2 11.6 12.3
[No. GP home visits daytime 1 year] 1.2 1.4 1.2 1.3 1.5 1.4
[No. GP home visits after hours 1 year] 0.7 0.8 0.8 0.8 0.7 0.7
Squared brackets indicate means. % indicates the proportion of cases in percent. Abbreviations: resp., respiratory; GP, general prac-
titioner.
Incidence, outcome, patients, and care 555however, unlikely, since increasing awareness of COPD and
economic incentives to detect and diagnose COPD has
characterised our study period.29 Furthermore, if COPD
diagnoses were increasingly restricted to more severe
cases, then the average length of stay should have
increased. Instead it decreased, supporting the conclusion
that it was in fact the use of COPD hospitalisation beds that
was restricted.
Perspectives
COPD hospitalisations have become increasingly restricted
to more severe cases. Therefore each COPD bed day
probably demands more resources. Since this development
seems to follow reductions in hospitals and beds for
internal medicine it may be the same for many other
diseases. Healthcare systems all over the world aim to
provide high quality benefits at the lowest cost, and
treating diseases like COPD in primary care instead of
hospitals has in the recent years been a major focus of this
endeavour.30,31 In agreement with other studies,32,33 this
study has demonstrated improvements in the COPD treat-
ment in Danish primary healthcare. These improvements
may have led to postponement of admission referrals and
made it possible to reduce the number of hospital beds.
Another interpretation of our findings is that the increased
restrictions in the use of COPD hospital beds were induced
by the reduction in hospital capacity resulting in the
increasingly overcrowded departments, which forced
general practice to treat increasingly severe cases. A
combination may be the case. Whether the restrictions in
the use of COPD hospital beds have affected the overall
quality of care for COPD patients is largely unknown, butthe Danish Registry of Causes of Death reports that the age-
and sex-standardised death rates from pulmonary diseases
in our study period were decreasing.34
The international debate about the extent and character
of changes in health and healthcare is often hampered by
lack of documentation. Our study provides valuable data
documenting changes within one of the most significant
diseases.
Conclusion
Decreasing rate of first-time COPD hospitalisations
combined with shorter lengths of stay and increasing
severity of cases indicates that the use of hospital beds for
COPD exacerbations has been gradually restricted. This
may be causally related to both the centralisation into
overcrowded departments and the improved outside
hospital treatment of COPD, also demonstrated in this
study.
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